Edition:
United States

Medtronic PLC (MDT)

MDT on New York Consolidated

74.99USD
20 Jan 2017
Change (% chg)

$-0.31 (-0.41%)
Prev Close
$75.30
Open
$75.51
Day's High
$75.68
Day's Low
$74.72
Volume
8,898,612
Avg. Vol
6,098,515
52-wk High
$89.27
52-wk Low
$69.35

Select another date:

Tue, Jan 17 2017

BRIEF-Medtronic says CE Mark, European launch of Recaptureable TAVI system now available for severe aortic stenosis patients with large anatomies

* Medtronic announces CE mark and european launch of recaptureable TAVI system now available for severe aortic stenosis patients with large anatomies Source text for Eikon: Further company coverage:

Medtronic must face revived U.S. lawsuit over Infuse

A federal appeals court on Wednesday revived a lawsuit accusing Medtronic Plc of defrauding shareholders by covering up negative side effects from its Infuse bone growth product for nearly a decade.

China says fines Medtronic local unit $17.2 million for price fixing

BEIJING/SHANGHAI A Chinese regulator has fined a local unit of U.S.-listed medical device firm Medtronic PLC 118.5 million yuan ($17.20 million) for price fixing, the National Development and Reform Commission (NDRC) said in a statement on Wednesday.

BRIEF-Medtronic announces U.S. launch of integrated health solutions

* Medtronic announces U.S. launch of integrated health solutions with university hospitals agreement Source text for Eikon: Further company coverage:

BRIEF-Medtronic first to receive european approval for less-invasive HVAD implant procedure

* Medtronic first to receive european approval for less-invasive HVAD implant procedure Source text for Eikon: Further company coverage:

BRIEF-Medibio enters into binding agreement with Medtronic

* Asx alert-medibio enters into binding agreement with medtronic-meb.ax

Medtronic sales disappoint, firm lowers forecast; shares fall

Medtronic Plc on Tuesday reported quarterly sales below Wall Street's expectations for virtually all its major product lines and cut its full-year earnings forecast, and the medical device maker's shares fell more than 8 percent.

UPDATE 4-Medtronic sales disappoint, firm lowers forecast; shares fall

Nov 22 Medtronic Plc on Tuesday reported quarterly sales below Wall Street's expectations for virtually all its major product lines and cut its full-year earnings forecast, and the medical device maker's shares fell more than 8 percent.

BRIEF-Medtronic CEO says disappointed by Q2, but headwinds are largely temporary: Conf Call

* Medtronic CEO says he expects pressures in CRHF (part of Medtronic's heart division) to continue through the fiscal year

Medtronic's quarterly revenue rises 4 pct

Nov 22 Medtronic Plc, the world's largest standalone medical device maker, reported a 4 percent rise in quarterly revenue, helped by higher demand for its minimally invasive devices and heart products.

Select another date: